Nuevo tratamiento para la Psoriasis.Actualizado en marzo del 2012.Dermatologia.


Source:El sitio web de Dermatología de INFOMED, Portal de la Medicina en Cuba.http://www.sld.cu/sitios/dermatologia/

Otros articulos:

21 Marzo 2012

New Psoriasis Treatment Yields Favorable Safety, Efficacy Profile

Archivado en: Actualidad dermatologica — dermatologia @ 18:38

News Author: Troy Brown
CME Author: Hien T. Nghiem, MD

Faculty and Disclosures

CME Released: 03/05/2012; Valid for credit through 03/05/2013
CME Information Earn CME Credit »
Clinical Context

Psoriasis is a difficult skin disease to treat and usually requires long-term use of systemic therapies to achieve adequate disease control. Multiple systemic therapies are currently available; however, unmet needs remain for safe and effective long-term psoriasis treatments. Psoralen plus ultraviolet A is associated with photo-aging and increased risks for cutaneous malignant diseases, whereas while ultraviolet B phototherapy has limited data. Long-term use of systemic therapies has been associated with cumulative end-organ toxicities (eg, hepatotoxicity with methotrexate and nephrotoxicity with cyclosporine).

Ustekinumab has been shown to be highly efficacious in the treatment of moderate to severe plaque psoriasis. Results of the Psoriasis Followed by Long-Term Extension (PHOENIX) 1 study reported to date have described the efficacy and safety of ustekinumab for psoriasis through week 76. The aim of this study by Kimball and colleagues was to evaluate the efficacy and safety of ustekinumab through 3 years in the PHOENIX 1 trial.
Study Synopsis and Perspective

Researchers have found that ustekinumab, a novel interleukin 12 (IL-12) and IL-23 antagonist, has a favorable benefit–risk profile for up to 3 years of treatment for moderate to severe psoriasis.

Alexandra Boer Kimball, MD, MPH, associate professor in the Department of Dermatology at Harvard Medical School in Boston, Massachusetts, and colleagues reported their findings in an article published online February 22 in the British Journal of Dermatology.

Ver

http://www.medscape.org/viewarticle/759649?src=cmemp

(!)Ustekinumab Safe, Effective in Long-Term Psoriasis Treatment… for up to 3 years of treatment for moderate to severe psoriasis. Alexandra Boer Kimball, MD, MPH, associate professor in the Department of …

News, Medscape Medical News, February 2012

Etiquetas: , , ,

3 comentarios to “Nuevo tratamiento para la Psoriasis.Actualizado en marzo del 2012.Dermatologia.”

  1. site Says:

    site…

    Nuevo tratamiento para la Psoriasis.Actualizado en marzo del 2012.Dermatologia. « Nepabuleici’s Blog…

  2. hcg diet Says:

    I was curious if you ever thought of changing
    the layout of your site? Its very well written; I love what youve got
    to say. But maybe you could a little more in the way of content so people could connect with it better.
    Youve got an awful lot of text for only having 1 or two images.
    Maybe you could space it out better?

  3. snore remedy Says:

    This paragraph offers clear idea designed for the new viewers of blogging,
    that in fact how to do running a blog.

Deja un comentario

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión / Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión / Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión / Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión / Cambiar )

Conectando a %s


Seguir

Recibe cada nueva publicación en tu buzón de correo electrónico.

Únete a otros 184 seguidores

%d personas les gusta esto: